ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 230 out of 780

$558K Total Retail Price of All Prescriptions

Rank: 262 out of 780

298 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 10,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 425 356 1 5
OMEPRAZOLE 410 312 2 3
SIMVASTATIN 366 299 3 2
FUROSEMIDE 334 318 4 7
HYDROCODONE-ACETAMINOPHEN 325 299 S3 5 1
NAMENDA 269 269 6 46
BENAZEPRIL HCL 219 147 7 59
POTASSIUM CHLORIDE 216 200 8 11
AMLODIPINE BESYLATE 205 170 9 4
MUPIROCIN 205 205 9 173
METFORMIN HCL 202 161 11 8
GABAPENTIN 192 153 12 13
CITALOPRAM HBR 191 178 13 23
PREDNISONE 168 155 14 40
QUETIAPINE FUMARATE 159 136 15 81
NYSTATIN 158 148 16 203
LISINOPRIL 153 141 17 6
POLYETHYLENE GLYCOL 3350 145 142 18 79
CARVEDILOL 137 111 19 14
FAMOTIDINE 135 132 20 86
WARFARIN SODIUM 133 122 21 24
MIRTAZAPINE 132 127 22 58
SERTRALINE HCL 131 118 23 27
DESONIDE 127 119 24 303
METOPROLOL TARTRATE 125 125 25 19
ALBUTEROL SULFATE 123 122 26 163
TRAZODONE HCL 123 100 26 35
DONEPEZIL HCL 122 122 28 31
MELOXICAM 110 97 29 16
LANTUS 110 104 29 71
CLOPIDOGREL 106 92 31 34
TRAMADOL HCL 104 98 32 15
FLUTICASONE PROPIONATE 102 81 33 41
ROPINIROLE HCL 102 88 33 87
DIGOXIN 100 100 35 56
DIVALPROEX SODIUM 99 77 36 119
METOPROLOL SUCCINATE 98 90 37 20
PLAVIX 93 88 38 45
LEVETIRACETAM 93 87 38 130
CLONIDINE HCL 92 73 40 28
GLIMEPIRIDE 91 79 41 30
ATENOLOL 90 74 42 21
ZOLPIDEM TARTRATE 89 76 43 17
IPRATROPIUM BROMIDE 85 83 44 238
TAMSULOSIN HCL 80 80 45 36
ALLOPURINOL 77 57 46 29
NEXIUM 75 42 47 22
ATORVASTATIN CALCIUM 73 57 48 12
METOCLOPRAMIDE HCL 72 42 49 102
LOSARTAN POTASSIUM 66 61 50 18
BUPROPION HCL SR 65 37 51 193
SEROQUEL 64 55 52 172
RANITIDINE HCL 63 51 53 39
CARBIDOPA-LEVODOPA 63 63 53 124
HYDROCHLOROTHIAZIDE 63 56 53 10
PROMETHAZINE HCL 61 58 R 56 66
RAMIPRIL 59 50 57 70
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 58 50
LIDODERM 57 57 59 224
LYRICA 57 47 59 52
NOVOLIN R 57 57 59 212
MEGESTROL ACETATE 56 56 R 62 161
CYMBALTA 55 41 63 51
ENALAPRIL MALEATE 52 36 64 64
AMIODARONE HCL 50 37 65 139
DOXYCYCLINE HYCLATE 50 36 65 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.